Pneumonia Clinical Trials

248 recruitingLast updated: June 17, 2026

There are 248 actively recruiting pneumonia clinical trials across 74 countries. Studies span Not Applicable, Phase 3, Phase 4, Phase 2, Phase 1, Early Phase 1. Top locations include Paris, France, Tours, France, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Pneumonia Trials at a Glance

248 actively recruiting trials for pneumonia are listed on ClinicalTrialsFinder across 6 cities in 74 countries. The largest study group is Not Applicable with 76 trials, with the heaviest enrollment activity in Paris, Tours, and Beijing. Lead sponsors running pneumonia studies include Assistance Publique - Hôpitaux de Paris, Nantes University Hospital, and Pfizer.

Treatments under study

About Pneumonia Clinical Trials

Looking for clinical trials for Pneumonia? There are currently 109 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pneumonia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pneumonia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 248 trials

Recruiting

Combination vs. Monotherapy for Stenotrophomonas Maltophilia Infections

bloodstream infectionPneumonia, BacterialS Maltophilia Infections
Instituto de Investigación Sanitaria Gregorio Marañón790 enrolled1 locationNCT07593547
Recruiting

Study of Lung Proteins in Patients With Pneumonia

Pulmonary DiseasePneumoniaLung Disease
National Institutes of Health Clinical Center (CC)750 enrolled1 locationNCT00077909
Recruiting

Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)

PneumoniaInfectionsImmune System Diseases+2 more
National Institute of Allergy and Infectious Diseases (NIAID)600 enrolled1 locationNCT00006150
Recruiting

Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.

COVID-19 pneumoniaCardiovascular DiseasesPneumonia, Community-Acquired
Hellenic Institute for the Study of Sepsis650 enrolled18 locationsNCT06601998
Recruiting

Pneumococcal Carriage, Serotypes, and Antibiotic Resistance in Malaysian Children: A Multi-Centre Study

Nasopharyngeal Carriage of Streptococcus Pneumoniae
IMU University, Malaysia600 enrolled4 locationsNCT07545876
Recruiting

Fungal Infection Susceptibility

Cryptococcal MeningitisCryptococcosisCryptococcal Infection+2 more
National Institute of Allergy and Infectious Diseases (NIAID)800 enrolled1 locationNCT00001352
Recruiting
Not Applicable

Long-term Alterations of Host-microbiome Interactions and Cardiovascular and Respiratory Diseases Progression After Pneumonia

Hospital Acquired Pneumonia (HAP)Cardiovascular and Respiratory Disease
Nantes University Hospital300 enrolled5 locationsNCT06602934
Recruiting
Not Applicable

Effectiveness of Best Care Practices in Acute Stroke in Conventional Hospitalization (BEST CARE ICTUS_HC)

StrokeCerebrovascular DisordersAcute Stroke+6 more
University of Malaga700 enrolled4 locationsNCT07627399
Recruiting
Phase 3

Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation

PneumoniaSeptic ShockThe Critically Ill Patient is Requiring Intubation
Helwan University41 enrolled2 locationsNCT07530146
Recruiting
Phase 4

Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma

Lymphoma, Non-HodgkinStreptococcus PneumoniaeVaccine
Poitiers University Hospital160 enrolled7 locationsNCT04460235
Recruiting
Phase 2

A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory Failure

Pneumonia
MiNK Therapeutics90 enrolled4 locationsNCT07615010
Recruiting
Early Phase 1

iNO300 Therapy in Critically Ill Patients With Pneumonia

PneumoniaCritical Illness
Massachusetts General Hospital34 enrolled1 locationNCT06950294
Recruiting

Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort Study

bloodstream infectionSepsisPneumonia+1 more
Sichuan Provincial People's Hospital200 enrolled1 locationNCT07601711
Recruiting

Pulmonary Microbiota Changes and Clinical Outcomes in Neurosurgical ICU Patients With Artificial Airways

Ventilator-Associated Pneumonia (VAP)Microbiome DysbiosisIntensive Care Unit (ICU) Patients
Jian-Xin Zhou220 enrolled3 locationsNCT07129174
Recruiting
Not Applicable

Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mechanical Ventilation

Pneumonia
Zhongnan Hospital96 enrolled1 locationNCT07453966
Recruiting
Not Applicable

Ultrasound and Respiratory Physiological Signals in Lung Diseases

UltrasoundChronic Obstructive Pulmonary DiseaseInterstitial Lung Disease+5 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS25 enrolled1 locationNCT06068647
Recruiting

Innate Immune Immunoparalysis and Ventilator-Associated Pneumonia in Critically Ill Elderly Patients

Ventilator-Associated Pneumonia (VAP)Intubated ICU PatientsImmunoparalysis
Hospital Universitari de Bellvitge170 enrolled1 locationNCT07551258
Recruiting
Phase 3

Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute Coronary Syndrome Patients With Pneumonia, With or Without Influenza Vaccination

PneumoniaCOPD, Chronic Obstructive Pulmonary Diseaseacute coronary syndromes (ACS)
University of Brawijaya60 enrolled1 locationNCT07604103
Recruiting
Not Applicable

Colistin Methanesulfonate Sodium Inhalation for Prophylaxis of Ventilator-Associated Pneumonia (CIVAP): A Prospective, Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial

Ventilator-Associated Pneumonia (VAP)
Qilu Hospital of Shandong University508 enrolled1 locationNCT06834971
Recruiting
Not Applicable

Skeletal Muscle Function in Interstitial Lung Disease

Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisScleroderma+2 more
University of British Columbia40 enrolled1 locationNCT03800017